Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
Vivace Therapeutics, Inc
Vivace Therapeutics, Inc
AstraZeneca
TCR2 Therapeutics
Incyte Corporation
Molecular Templates, Inc.
Bristol-Myers Squibb
Incyte Corporation
Infinity Pharmaceuticals, Inc.